Genomics are the complete set of genes or genetic material present in a cell or organism. The goal of genomics is to promote the understanding of the structure, function, and evolution of genomes in all living organism and plants. Genomics yields information which have transformed the health services. Genomics helps in reveal the causes of killer diseases such as cancer, diabetes, cardiac stroke etc. The human genome consists of 46 chromosomes. As per the definition from the United States Environmental Protection Agency, genomics concerns a wider line of scientific inquiry and associated techniques than it did initially. Genomics market involves the study of all genes at the DNA, mRNA, proteome level as well as the cellular or tissue level.

Increased demand for genetically modified animals and plants, use of genomics concepts in the field of synthetic biology, study gene sequences of plants and organisms, massive changes in technology that allowed researchers to interrogate larger pieces of the human genome is expected to drive the global genomics market. However, the high cost of genomic instruments is one of the major restraints of the market.

Currently, the genomics industry as a whole is shifting from early stage adoption, where the focus has been on technology and new research, where providers are starting to integrate genetic services. Food and Drug Administration (FDA) is increasing its attention on the genetics industry.

Do Inquiry of the Report Here:

Among all the regions, the market in North America dominates the global genomics market, owing to research grants and funds in the US and support from key industrial players is helping in the growth of genomics in this region. Asia Pacific genomics market is expected to be an emerging market for genomics due various government initiatives for the genomic research in order to understand the complex biological process and genetic mutation present in life-threatening diseases.

Prominent players in the global genomics market are, F. Hoffmann-La Roche Ltd., Bayer AG, Affymetrix Inc., Agilent Technologies, Inc., Myriad Genetics, Inc., Qiagen Inc., Illumina Inc., GE Healthcare Limited, Eurofins Scientific, Inc., and Bio-Rad Laboratories, Inc.